Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment

CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.

Original Source

Read the full article at Cnbc →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.